Skip to main content
. 2017 Dec 8;9:409. doi: 10.3389/fnagi.2017.00409

Figure 6.

Figure 6

Effect of DL0410 on inflammation via the RAGE/NF-κB pathway in the hippocampus and cortex. Data are the mean ± SEM (n = 4–6). (A) Representative bands. (B) DL0410 could reduce the expression of RAGE in the hippocampus and cortex (cortex F(6,17) = 5.012, p = 0.0040, hippocampus F(6,21) = 5.435, p = 0.0016). (C) DL0410 could decrease the expression of pNF-κB in the hippocampus and cortex (cortex F(6,28) = 5.234, p = 0.0010, hippocampus F(6,28) = 7.956, p < 0.0001). (D) DL0410 could decrease the expression of cyclooxygenase-2 (COX2) in the hippocampus and cortex (cortex F(6,27) = 5.096, p = 0.0013, hippocampus F(6,16) = 4.438, p = 0.0079). (E) DL0410 could decrease the expression of iNOS in the hippocampus and cortex (cortex F(6,13) = 2.756, p = 0.0592, hippocampus F(6,26) = 3.149, p = 0.0186). #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs. control group, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. model group.